The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Viral load testing trial finds 49% are virally unsuppressed while one in five are failing their treatment with suspected drug resistance.
Study identifies new structural drivers of Uganda’s HIV epidemic alongside the persistence of known drivers such as stigma and gender-based violence.
Two-thirds of people with second-line treatment failure can reach viral suppression following adherence support in West Africa.
Switching from an antiretroviral treatment (ART) regimen containing tenofovir disoproxil fumarate (TDF) to a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide (ECETA) can improve bone density and kidney safety in those aged 60 and above, new study finds.
Delayed language development found in HIV-negative two-year-olds exposed to the virus during pregnancy.
Vouchers can play a role in empowering more women to take up early contraceptive services after pregnancy.
Qualitative study in Mozambique highlights how structural challenges around viral load monitoring can disempower health workers and people living with HIV.
Baseline HIV testing data reveals sub-optimal testing rates among those living in the most heavily burdened areas of the USA.
New study finds that questionnaire can improve self-report measures of adherence in children at low-cost.
Differentiated care models need further investigation to support people living with HIV with taking their antiretroviral treatment (ART).